585 related articles for article (PubMed ID: 15492182)
21. A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase/dismutase superoxide in vitiligo.
Sanclemente G; Garcia JJ; Zuleta JJ; Diehl C; Correa C; Falabella R
J Eur Acad Dermatol Venereol; 2008 Nov; 22(11):1359-64. PubMed ID: 18624857
[TBL] [Abstract][Full Text] [Related]
22. Comparison between autologous noncultured extracted hair follicle outer root sheath cell suspension and autologous noncultured epidermal cell suspension in the treatment of stable vitiligo: a randomized study.
Singh C; Parsad D; Kanwar AJ; Dogra S; Kumar R
Br J Dermatol; 2013 Aug; 169(2):287-93. PubMed ID: 23517382
[TBL] [Abstract][Full Text] [Related]
23. Childhood vitiligo: a long-term study of localized vitiligo treated by noncultured cellular grafting.
Mulekar SV; Al Eisa A; Delvi MB; Al Issa A; Al Saeed AH
Pediatr Dermatol; 2010; 27(2):132-6. PubMed ID: 19804496
[TBL] [Abstract][Full Text] [Related]
24. Pimecrolimus cream in repigmentation of vitiligo.
Seirafi H; Farnaghi F; Firooz A; Vasheghani-Farahani A; Alirezaie NS; Dowlati Y
Dermatology; 2007; 214(3):253-9. PubMed ID: 17377388
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
26. Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study.
Saraceno R; Nisticò SP; Capriotti E; Chimenti S
Dermatol Ther; 2009; 22(4):391-4. PubMed ID: 19580584
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
[TBL] [Abstract][Full Text] [Related]
28. Treatment of stable vitiligo by ReCell system.
Cervelli V; De Angelis B; Balzani A; Colicchia G; Spallone D; Grimaldi M
Acta Dermatovenerol Croat; 2009; 17(4):273-8. PubMed ID: 20021980
[TBL] [Abstract][Full Text] [Related]
29. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients.
Linthorst Homan MW; Spuls PI; Nieuweboer-Krobotova L; de Korte J; Sprangers MA; Bos JD; Wolkerstorfer A; van der Veen JP
J Eur Acad Dermatol Venereol; 2012 Jun; 26(6):690-5. PubMed ID: 21711467
[TBL] [Abstract][Full Text] [Related]
30. Twelve-month and sixty-month outcomes of noncultured cellular grafting for vitiligo.
Gan EY; Kong YL; Tan WD; Thng ST; Goh BK
J Am Acad Dermatol; 2016 Sep; 75(3):564-571. PubMed ID: 27180264
[TBL] [Abstract][Full Text] [Related]
31. Characterization of clinical response in patients with vitiligo undergoing autologous epidermal punch grafting.
Feetham HJ; Chan JL; Pandya AG
Dermatol Surg; 2012 Jan; 38(1):14-9. PubMed ID: 22093284
[TBL] [Abstract][Full Text] [Related]
32. Modified technique of autologous noncultured epidermal cell transplantation for repigmenting vitiligo: a pilot study.
van Geel N; Ongenae K; De Mil M; Naeyaert JM
Dermatol Surg; 2001 Oct; 27(10):873-6. PubMed ID: 11722524
[TBL] [Abstract][Full Text] [Related]
33. Erbium:YAG laser and cultured epidermis in the surgical therapy of stable vitiligo.
Guerra L; Primavera G; Raskovic D; Pellegrini G; Golisano O; Bondanza S; Paterna P; Sonego G; Gobello T; Atzori F; Piazza P; Luci A; De Luca M
Arch Dermatol; 2003 Oct; 139(10):1303-10. PubMed ID: 14568835
[TBL] [Abstract][Full Text] [Related]
34. A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo.
Agarwal S; Ramam M; Sharma VK; Khandpur S; Pal H; Pandey RM
Br J Dermatol; 2005 Jul; 153(1):163-6. PubMed ID: 16029343
[TBL] [Abstract][Full Text] [Related]
35. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
36. Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting.
Mulekar SV; Al Issa A; Al Eisa A
Dermatol Surg; 2009 Jan; 35(1):66-71. PubMed ID: 19076191
[TBL] [Abstract][Full Text] [Related]
37. Long-term results of noncultured epidermal cellular grafting in vitiligo, halo naevi, piebaldism and naevus depigmentosus.
van Geel N; Wallaeys E; Goh BK; De Mil M; Lambert J
Br J Dermatol; 2010 Dec; 163(6):1186-93. PubMed ID: 20804490
[TBL] [Abstract][Full Text] [Related]
38. Treatment of vitiligo by transplantation of cultured pure melanocyte suspension: analysis of 120 cases.
Chen YF; Yang PY; Hu DN; Kuo FS; Hung CS; Hung CM
J Am Acad Dermatol; 2004 Jul; 51(1):68-74. PubMed ID: 15243526
[TBL] [Abstract][Full Text] [Related]
39. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
Bhatnagar A; Kanwar AJ; Parsad D; De D
J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
[TBL] [Abstract][Full Text] [Related]
40. Treatment of localized vitiligo by autologous minigrafting.
Falabella R
Arch Dermatol; 1988 Nov; 124(11):1649-55. PubMed ID: 3052304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
